Case Study: Developing a Receptor-Targeted Peptide Oligonucleotide Conjugate for Muscle Delivery in Duchenne Muscular Dystrophy

Introduction: A receptor-targeted peptide oligonucleotide conjugate (POC) is an engineered biotherapeutic that links an antisense oligonucleotide (ASO) payload to a … Continue reading Case Study: Developing a Receptor-Targeted Peptide Oligonucleotide Conjugate for Muscle Delivery in Duchenne Muscular Dystrophy